- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01637948
Controlled Clinical Trial of Traditional Chinese Medicine Mouthrinse
July 10, 2012 updated by: Wong Wing Kit, Ricky, The University of Hong Kong
Controlled Clinical Trial of Traditional Chinese Medicine Mouthrinse In Improving Oral Health in Orthodontic Patients
Traditional Chinese medicine (TCM) has been seen as the predominant way of treating disease in China over three thousand years.
Certain TCM have scientifically proved to have anti-bacterial property.
Patients having orthodontic treatment have higher risks of caries and gum diseases.
The purpose of this study was to determine whether the use of TCM Mouthrinses in addition to toothbrushing and flossing has an added benefit for orthodontic patients in maintaining proper oral health.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The aim of this study was to investigate the effects of a Traditional Chinese medicine (TCM) mouthrinse on gingival health and microbial profiles in orthodontic patients.
This six-month randomized, single-blinded, parallel controlled clinical trial consists of 90 patients with fixed appliance treatment.
The subjects were allocated to (1) negative-control group: oral hygiene instruction (OHI) alone; (2) positive-control group: OHI plus an EO mouthrinse (Listerine®)(3) test group: OHI plus the TCM mouthrinse (5% Fructus mume extract).
Clinical examinations included Plaque Index (PI), Bleeding Index (BI) and Modified Gingival Index (MGI).
Salivary microbial quantifications included total aerobic and anaerobic bacteria, Streptococci and Lactobacilli counts.
Clinical and microbiological examinations were conducted at baseline, 3 and 6 months (T1, T2 and T3).
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hong Kong, China
- Faculty of Dentistry, HKU
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 35 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects who have at less 20 permanent teeth
- Subjects who have a healthy systemic condition
- Subjects with age range 13-35.
- Subjects who are no-smoker;
- Subjects who haven't taken antibiotic medicine within a 2 week period prior
- Subjects who do not currently undergo any medication or will undergo any medication in next six months
- Subjects who have not dental diseases that required ongoing treatment, which would confound the evaluation of result
- Subjects who are competent in giving consents
- Subjects who are not pregnant or lactating women
- Subjects who do not report teeth sensitivity
- Subjects who are not allergic to ethanol
- Subjects presented a minimum level of pre-existing gingivitis (MGI>1) but without peridontitis.(probing depth>4mm)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Listerine
essential oil mouthrinse
|
For six months
Other Names:
|
No Intervention: Negative control
without intervention
|
|
Experimental: Chinese medicine mouthrinse
5% Fructus Mume extract and 2% sodium bicarbonate
|
six months
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gingival index
Time Frame: 6 months
|
Modified gingival index
|
6 months
|
Plaque index
Time Frame: 6 months
|
plaque index
|
6 months
|
gingival bleeding index
Time Frame: 6 months
|
gingival bleeding index
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Salivary cytokines
Time Frame: 6 months
|
Salivary inflammatory cytokines (IL-1β and MIF) levels were detected by ELISA assay.
|
6 months
|
Adverse Events
Time Frame: 6 months
|
the number of participants with side effects or adverse events were recorded throughout the whole study time.
|
6 months
|
Salivary bacteria counts
Time Frame: 6 months
|
Salivary microbial quantifications included total aerobic and anaerobic bacteria, streptococci and lactobacilli counts.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ricky Wong, PhD, Faculty of Dentistry, The University of Hong Kong
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Actual)
May 1, 2011
Study Completion (Actual)
January 1, 2012
Study Registration Dates
First Submitted
January 3, 2012
First Submitted That Met QC Criteria
July 10, 2012
First Posted (Estimate)
July 11, 2012
Study Record Updates
Last Update Posted (Estimate)
July 11, 2012
Last Update Submitted That Met QC Criteria
July 10, 2012
Last Verified
July 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HKCTR-1145
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gingivitis
-
Zainab J AbbasCompleted
-
University of SaskatchewanCompletedChronic Gingivitis | Chronic Gingivitis, Plaque InducedCanada
-
Tufts UniversityGuangdong Bixdo Health Technology Co., Ltd.Not yet recruitingPlaque Induced GingivitisUnited States
-
Cairo UniversityNot yet recruiting
-
Hospital Universiti Sains MalaysiaRecruitingGingivitis | Plaque Induced GingivitisMalaysia
-
Lander Enterprises, LLCCompletedPlaque Induced GingivitisUnited States
-
University of WashingtonColgate PalmoliveCompleted
-
Tokat Gaziosmanpasa UniversityAbant Izzet Baysal UniversityCompletedPregnancy Gingivitis
-
Maharishi Markendeswar University (Deemed to be...CompletedChronic GingivitisIndia
-
Ain Shams UniversityCompleted
Clinical Trials on Listerine mouthrinse
-
University of LisbonInstituto PiagetCompleted
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedGingivitis | PlaqueUnited States
-
Assistance Publique - Hôpitaux de ParisSociété Française de Parodontologie et d'Implantologie Orale (SFPIO)CompletedAnti-CCP Positive Early Rheumatoid ArthritisFrance
-
University of LisbonInstituto PiagetCompletedGingivitis | Dental Plaque AccumulationPortugal
-
InQpharm GroupCompletedDentin SensitivityGermany
-
Yağmur Saraç GülRecep Tayyip Erdogan University Scientific Research Projects CoordinatorCompletedInflammation | Oxidative Stress | Gingivitis; ChronicTurkey
-
University of ChileFundación Debra ChileEnrolling by invitationOral Ulcer | Epidermolysis BullosaChile
-
Universiti Sains Islam MalaysiaCompletedPlaque Accumulation | Patient AcceptanceMalaysia
-
Indiana Nanotech, LLCThe University of Texas Health Science Center at San AntonioCompleted
-
Johnson & Johnson Consumer and Personal Products...Completed